EP1282432 - Bibliographic data

USE OF PEPTIDE ANTAGONISTS OF ZONULIN FOR PREVENTION OR DELAY OF THE ONSET OF DIABETES

Last update 10/07/2025
Legal status Brevet déchu
Origin Euro-PCT

(73) Holder

UNIVERSITY OF MARYLAND, BALTIMORE

520 W. Lombard Street
Baltimore, Maryland 21201-1627
États-Unis d'Amérique
(72) Inventors

FASANO, Alessio

3128 River Valley Chase
West Friendship, MD 21794
États-Unis d'Amérique

WATTS, Tammara, L.

156 Wilson Street
Baltimore, MD 21217
États-Unis d'Amérique
(74) Agent

Mail recipient

LEATHLEY, ANNA ELISABETH

Dehns St Bride`s House 10 Salisbury Square
London EC4Y 8JD
Royaume-Uni

(21) Request number EP01922244.7
(22) Request date 21/03/2001

(11) Publication number EP1282432
Publication date 05/08/2009

(54) Title of the invention USE OF PEPTIDE ANTAGONISTS OF ZONULIN FOR PREVENTION OR DELAY OF THE ONSET OF DIABETES
(51) International classification A61K 38/00A61K 38/16C07K 7/00C07K 14/00C07K 17/00
International classification (before reform) None

Claimed priority

(31) Number: 205305 P
(32) Date: 19/05/2000
(33) Country: US

Initial application None
Divisional application None

Expected annuity Annuity: 10 - Amount: 135 € - Due date 31/03/2010
Surtax: 10 - Amount: 27 € - Due date 01/10/2010
Last annuity None

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2009/3, of 30/09/2009

History

Publication de la délivrance du brevet européen - Legal date 05/08/2009


Déchéance du brevet d'invention après période de grâce - Legal date 31/03/2010


Entrée en période de grâce du brevet d'invention - Legal date 31/03/2010